Related Experiment Video
Updated: Aug 19, 2026

08:41
Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors
Yongxin Han1, André Giroux, John Colucci
1Department of Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co., PO Box 1005, Pointe-Claire-Dorval, Quebec, Canada H9R 4P8. yongxin_han@merck.com
Bioorganic & Medicinal Chemistry Letters
|February 3, 2005
Abstract:
The iterative process for the discovery of a series of pyrazinone mono-amides as potent, selective and reversible non-peptide caspase-3 inhibitors (e.g., M826 and M867) is reported. These compounds display potent anti apoptotic activities in a number of cell based systems in vitro as well as in several animal models in vivo.

